FOXD2 and acute myeloid leukemia: We identified that AML cases with upregulation of FOXD2-AS1, CDK1, and CDC45 had shorter OS and RFS than those with low levels of FOXD2-AS1, CDK1, and CDC45 expression (Fig. 4).